Mann Chandavimol

Interventional cardiologist / Cardiologist
Ramathibodi Hospital - Bangkok, Thailand

Latest contributions

Management of non-culprit lesions in patients with ACS and multivessel disease

21 May 2025 – From EuroPCR 2025

This session addresses the optimal management of non-culprit lesions (NCL) in patients with acute coronary syndrome (ACS) and multivessel disease. Learn about angiography, imaging, and FFR-guided strategies, timing considerations for PCI in high-risk NSTEMI patients, and patient selection for early staged PCI post-STEMI through detailed case...

Management of non-culprit lesions in patients with ACS and multivessel disease

TAVI burning issues

09 Feb 2025 – From PCR Tokyo Valves 2025

This comprehensive session delves into the 'burning issues' in TAVI, covering a wide range of topics. Discover the impact of catheter insertion on left ventricular pacing, the importance of the en-face view for coronary cannulation, comparisons of TAVI valve expansions, indications for left and right ventricular...

TAVI burning issues

TAV-in-SAV - Part 1

08 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the complex world of TAV-in-SAV (Transcatheter Aortic Valve-in-Surgical Aortic Valve) in this comprehensive session. Explore various case studies, including valve-in-valve TAVI in a patient with structural valve deterioration, a successful case of balloon-assisted BASILICA for TAV-in-TAV, and TAVI after valve sparing aortic replacement. Gain...

TAV-in-SAV - Part 1

TAV-in-TAV

08 Feb 2025 – From PCR Tokyo Valves 2025

Watch this PCR Tokyo Valves 2025 session on TAV-in-TAV to discover essential insights on optimizing the procedure. Learn how CT analysis and precise measurements are critical for success, and why coronary protection, chimney stenting, and leaflet modification must be considered in high-risk cases. Experts discuss key...

TAV-in-TAV

Lifetime management - First valve choice matters

08 Feb 2025 – From PCR Tokyo Valves 2025

In this expert-led session, explore new frontiers in TAVI, focusing on bicuspid aortic valves, small annulus, and the risk of secondary interventions. Gain insights from the latest randomized trials (RHEIA) and registry data (CAvEAT), with real-world case discussions highlighting their clinical impact.

Lifetime management - First valve choice matters

Mastering excellence: from valve selection to optimal outcomes with the Evolut TAVI system

07 Feb 2025 – From PCR Tokyo Valves 2025

Watch this expert-led session on the latest Evolut TAVI advancements, device selection for small annulus cases, and strategies for complex anatomies. Learn about redo-TAVI feasibility and key 1-year data from the SMART trial.

Mastering excellence: from valve selection to optimal outcomes with the Evolut TAVI system

Mastering techniques from basic to complex - Complex scenarios

07 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the complexities of TAVI (Transcatheter Aortic Valve Implantation) in this comprehensive session. Gain insights into the challenges of TAV-in-TAV procedures and the new terminologies associated with them. Discover strategies to mitigate the risk of conduction disturbances after TAVI, and learn how to prepare for...

Mastering techniques from basic to complex - Complex scenarios

Facilitating coronary access after TAVI

17 Feb 2024 – From PCR Tokyo Valves 2024

What are the challenges in coronary access after TAVI and what techniques may be used to facilitate it? Join this session to learn the answers to that question, as well as gaining insight into how to optimize the coronary access in the index procedure.

Challenging cases with SAPIEN3 Vol II – heavy calcified annulus, narrow root and bicuspid

17 Feb 2019 – From PCR Tokyo Valves 2019

Consult this session to discover 3 challenging cases using SAPIEN3, with challenging anatomies related to calcified LVOT, small aortic annulus and bicuspid aortic valve.

Challenging cases with SAPIEN3 Vol II – heavy calcified annulus, narrow root and bicuspid